INVENTIVA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-28
Analyst
Van Lanschot Kempen
Equibles does not estimate personal net worth.
Zoe is recorded as Analyst at Van Lanschot Kempen. Zoe has spoken on 1 earnings call across 1 company, most recently for INVENTIVA on September 28, 2026. The companies whose calls Zoe spoke on are classified in the Healthcare sector.
“So with the Van Friburnore Phase 3 native top line readout in MASH expected in the next quarter, we were wondering what kind of data we can expect at the top line.”
Van Lanschot Kempen
Analyst
Transcript header (unverified)
INVENTIVA
Biotechnology · Healthcare
Inventiva H1 2026 financial report
INVENTIVA